Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
Recruiting · NCT06209736 · Registry updated 2025-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN | complement 3 glomerulopathy | Recruiting | Phase 2 | 2025-07-15 | NCT06209736 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Omeros Corporation | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||